Literature DB >> 23286747

Amyotrophic lateral sclerosis in Catalonia: a population based study.

Jesús Pradas1, Teresa Puig, Ricard Rojas-García, María Luisa Viguera, Ignasi Gich, Giancarlo Logroscino.   

Abstract

Our objective was to determine the incidence and clinical-epidemiological characteristics of an ALS cohort patient in Catalonia (Spain). We conducted a population based registry for a three-year period (1999-2001) in Catalonia (6,361,365 inhabitants) using several sources of information. The original El Escorial diagnostic criteria (1994) for ALS were applied for the classification of patients. New cases diagnosed between 1 January 1999 and 31 December 2001 were 215 (118 males and 97 females), with an annual crude incidence rate of 1.4/100,000 (95% CI 1.3-1.8). This rate showed a peak age between 75 and 79 years. The incidence rate was 1.6 (95% CI 1.5-2.2) in males and 1.2 (95% CI 1.1-1.7) in females. Prevalence at the end of the period was 5.4/100,000 of the total population. Median age at onset was 64.3 years. Onset of symptoms was bulbar or generalized in 38% of cases. Mean disease duration at diagnosis was 11.0 months. Median time of survival from onset was 30.8 months. In conclusion, ALS incidence in Catalonia is within the range of other countries across Europe with different geographic, environmental and socioeconomic situations. However, as in other studies conducted in the Mediterranean area, Catalonia incidence is in the lower range of rates in Europe.

Entities:  

Mesh:

Year:  2013        PMID: 23286747     DOI: 10.3109/21678421.2012.749915

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  11 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

3.  Stratification of ALS patients' survival: a population-based study.

Authors:  Benoît Marin; Philippe Couratier; Simona Arcuti; Massimiliano Copetti; Andrea Fontana; Marie Nicol; Marie Raymondeau; Giancarlo Logroscino; Pierre Marie Preux
Journal:  J Neurol       Date:  2015-10-30       Impact factor: 4.849

4.  Age-specific ALS incidence: a dose-response meta-analysis.

Authors:  Benoît Marin; Andrea Fontana; Simona Arcuti; Massimilano Copetti; Farid Boumédiene; Philippe Couratier; Ettore Beghi; Pierre Marie Preux; Giancarlo Logroscino
Journal:  Eur J Epidemiol       Date:  2018-04-23       Impact factor: 8.082

5.  UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort.

Authors:  Jose Manuel Vidal-Taboada; Alan Lopez-Lopez; Maria Salvado; Laura Lorenzo; Cecilia Garcia; Nicole Mahy; Manuel J Rodríguez; Josep Gamez
Journal:  J Neurol       Date:  2015-07-11       Impact factor: 4.849

6.  Referral bias in ALS epidemiological studies.

Authors:  Giancarlo Logroscino; Benoit Marin; Marco Piccininni; Simona Arcuti; Adriano Chiò; Orla Hardiman; James Rooney; Stefano Zoccolella; Philippe Couratier; Pierre-Marie Preux; Ettore Beghi
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

7.  The Barcelona Brain Health Initiative: A Cohort Study to Define and Promote Determinants of Brain Health.

Authors:  Gabriele Cattaneo; David Bartrés-Faz; Timothy P Morris; Javier Solana Sánchez; Dídac Macià; Clara Tarrero; Josep M Tormos; Alvaro Pascual-Leone
Journal:  Front Aging Neurosci       Date:  2018-10-11       Impact factor: 5.750

8.  Genetic analysis of ALS cases in the isolated island population of Malta.

Authors:  Rebecca Borg; Maia Farrugia Wismayer; Karl Bonavia; Andrew Farrugia Wismayer; Malcolm Vella; Joke J F A van Vugt; Brendan J Kenna; Kevin P Kenna; Neville Vassallo; Jan H Veldink; Ruben J Cauchi
Journal:  Eur J Hum Genet       Date:  2021-01-07       Impact factor: 4.246

Review 9.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Benoît Marin; Farid Boumédiene; Giancarlo Logroscino; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Massimilano Copetti; Pierre-Marie Preux; Ettore Beghi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

10.  The Barcelona Brain Health Initiative: Cohort description and first follow-up.

Authors:  Gabriele Cattaneo; David Bartrés-Faz; Timothy P Morris; Javier Solana Sánchez; Dídac Macià; Josep M Tormos; Alvaro Pascual-Leone
Journal:  PLoS One       Date:  2020-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.